UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program vs Tempus ECG-Low EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Canon Medical Systems Corporation
VS
by Tempus

AI Verdict

Tool A specializes in advanced cardiac motion tracking and measurement through the analysis of ultrasound images, providing detailed post-processing and planning capabilities. In contrast, Tool B focuses on analyzing 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction, serving as a screening tool for heart failure risk. While both are cardiology AI tools, they utilize different data inputs and address distinct stages of cardiac assessment.

Choose UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program if…

Choose UltraExtend NX CUW-U001S V2.0 if your practice requires comprehensive, in-depth analysis of cardiac ultrasound images, including advanced 2D and 3D motion tracking and precise quantification for complex procedural planning. This tool is ideal for cardiologists needing a robust offline workflow for detailed post-processing, data organization, and reporting of ultrasound data.

View UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program →

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if your primary goal is to quickly screen and identify patients aged 40 or older who may be at risk of heart failure by detecting signs of low Left Ventricular Ejection Fraction (LVEF ≤40%) from standard 12-lead ECG recordings. This AI software provides a straightforward binary output to aid clinicians in prioritizing further evaluation within a clinical diagnostic setting.

View Tempus ECG-Low EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program Tempus ECG-Low EF
Deployment On-premise (software application) Integrates with current ECG platforms and electronic health records (EHRs).
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program

UltraExtend NX emphasizes a 'complete offline workflow' and 'streamlined workflow' for advanced cardiac image analysis, including data organization, review, analysis, documentation, and reporting. This suggests a comprehensive yet optimized user experience for complex diagnostic and procedural planning tasks. While Tempus ECG-Low EF offers simplicity for screening, Tool A's focus on optimizing a more intricate workflow for detailed analysis indicates a higher achievement in usability for its domain.

Clinical Value

UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program

UltraExtend NX provides 'AI-enabled advanced cardiac motion tracking and measurement,' 'precise and reproducible cardiac quantification,' and 'robust tools for planning complex procedures.' This offers deep diagnostic insight and direct support for interventional procedures, impacting treatment decisions. Tempus ECG-Low EF aids in early identification of patients at risk of heart failure, which is valuable, but UltraExtend NX's capabilities for detailed diagnosis and procedural planning offer a more comprehensive clinical impact.

Pricing & Value

Tempus ECG-Low EF

Both tools require direct contact for pricing, offering no upfront transparency. However, Tempus ECG-Low EF explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) available. This clear communication on critical compliance aspects adds tangible value and reduces potential hurdles for healthcare organizations, making its overall value proposition more transparent.

Enterprise Readiness

Tempus ECG-Low EF

Tempus ECG-Low EF demonstrates stronger enterprise readiness with explicit confirmation of HIPAA compliance and BAA availability. Its deployment as 'software, integrated into healthcare facility workflows' also suggests a design for seamless adoption within existing enterprise environments. UltraExtend NX's HIPAA and BAA details require contacting the vendor, indicating less upfront clarity.

Innovation

Tempus ECG-Low EF

While both leverage AI, Tempus ECG-Low EF's application of AI to standard 12-lead ECGs to detect low LVEF is a more novel and potentially disruptive innovation, utilizing widely available data for early risk stratification. The extensive training dataset of over 930,000 ECGs further underscores its innovative development.

Support & Docs

UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program

Canon Medical Systems (Tool A) offers a more robust and clearly articulated support framework, including 24/7 phone support, a dedicated Customer Solutions Center for service and applications specialists, remote diagnostics, and a Customer Education and Training Portal with various learning resources and a Document Center. Tempus (Tool B) provides email and local representative support, but lacks the detailed, comprehensive support infrastructure publicly available for Canon.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program Tempus ECG-Low EF
Name UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program Tempus ECG-Low EF
Company Canon Medical Systems Corporation Tempus AI
Description FDA-cleared AI-enabled ultrasound image analysis program providing advanced cardiac motion tracking and measurement, facilitating offline analysis and optimizing workflow for physicians. FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure.
Primary Function Ultrasound image analysis for cardiac motion tracking and measurement ECG analysis for detection of low Left Ventricular Ejection Fraction (LVEF u226440%)
Key Features AI-enabled advanced cardiac motion tracking and measurement, 2D and 3D Wall Motion Tracking, Auto EF LV with Full-assist functions, Post-processing analysis, Complete offline workflow, Leverages Canon's raw data architecture, Precise and reproducible cardiac quantification, Robust tools for planning complex procedures. AI-powered algorithm for ECG analysis, Detects signs of low Left Ventricular Ejection Fraction (LVEF u226440%), Analyzes resting, non-ambulatory 12-lead ECG recordings, Provides a binary output (Low LVEF Detected / Not Detected), Aids in identifying patients 40+ years at risk of heart failure, Trained on a large dataset of over 930,000 ECGs from 170,000+ patients.
Specialties Cardiology, Cardiothoracic Surgery Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program and Tempus ECG-Low EF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

UltraExtend NX analyzes 2D and 3D ultrasound images for cardiac assessment. Tempus ECG-Low EF analyzes resting, non-ambulatory 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction.
UltraExtend NX offers advanced cardiac motion tracking, 2D/3D wall motion tracking, Auto EF LV, and robust tools for planning complex procedures based on 3D TEE data. Tempus ECG-Low EF provides a binary output (Low LVEF Detected / Not Detected) to aid in identifying patients at risk of heart failure, though it is not a stand-alone diagnostic tool.
UltraExtend NX is intended for Cardiology and Cardiothoracic Surgery. Tempus ECG-Low EF is designed for Cardiology, Emergency Medicine, and Internal Medicine.
UltraExtend NX is used for post-processing analysis of ultrasound images, providing precise cardiac quantification and aiding in complex procedure planning. Tempus ECG-Low EF helps clinicians identify patients aged 40 years or older at risk of heart failure by detecting signs of low LVEF from ECGs.
Tempus ECG-Low EF is intended for use in patients 40 years of age or older. UltraExtend NX does not specify an age criterion in its description.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.